Targeted dual antibiotics can cut deaths in high-risk S. aureus bacteremia

A study led by researchers from the Infectious Diseases Service of the Bellvitge University Hospital (HUB), the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) shows for the first time that a combination of…

Continue Reading

News Source: medicalxpress.com